Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
244 studies found for:    Open Studies | "Urinary Bladder Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Urinary Bladder Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting A Prospective Non-interventional Study in Overactive Bladder (OAB) Patients Prescribed Betmiga® as Part of Routine Clinical Practice
Conditions: Overactive Bladder;   Urgency Incontinence;   Urinary Bladder Overactive;   Urinary Bladder Diseases;   Urologic Diseases
Intervention: Drug: Betmiga®
2 Not yet recruiting SHTC - EUROPE-1 Synergo Hyperthermia-Chemotherapy by European Urologists' Research Operation Preserving Evolution Study I
Conditions: Urinary Bladder Neoplasms;   Urologic Neoplasms;   Urogenital Neoplasms;   Neoplasms;   Neoplasms by Site;   Urinary Bladder Diseases;   Urologic Diseases
Interventions: Device: Synergo + MMC;   Drug: Bacillus Calmette-Guérin
3 Recruiting This is a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive Bladder
Conditions: Overactive Bladder;   Urgency Incontinence;   Urinary Bladder Overactive;   Urinary Bladder Diseases\Urologic Diseases
Interventions: Drug: Solifenacin Succinate;   Drug: Mirabegron;   Drug: Placebo
4 Unknown  Prospective Multicenter Human Randomized Controlled Evaluation of NOTES® Cholecystectomy
Condition: Gall Bladder Diseases
Interventions: Procedure: NOTES Cholecystectomy;   Procedure: Laparoscopic Cholecystectomy
5 Unknown  Biomechanical Assessment of Level Gait in Patient's Status Post Bladder Exstrophy
Condition: Bladder Exstrophy
Intervention:
6 Recruiting Pre-TURBT TC-3 Gel Intravesical Instillation in NMIBC
Condition: Carcinoma of Urinary Bladder, Superficial
Interventions: Device: 40 mg MMC gel;   Other: Standard of care MMC mixed with water;   Device: 80 mg MMC gel
7 Recruiting Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer
Conditions: Bladder Cancer;   Carcinoma, Transitional Cell;   Renal Pelvis Cancer;   Ureter Cancer;   Urethra Cancer
Interventions: Drug: Enzalutamide;   Drug: Cisplatin;   Drug: Gemcitabine
8 Unknown  Assessing the OAB-8 Questionnaire as a Tool to Measure Treatment Outcome
Condition: Overactive Bladder
Intervention: Drug: DETRUSITOL
9 Recruiting Specified Drug Use-results Survey of Betanis Tablets
Condition: Overactive Bladder
Intervention: Drug: Betanis
10 Unknown  Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: selenium;   Drug: vitamin E;   Procedure: biopsy;   Procedure: chemoprevention;   Procedure: cryopreservation;   Procedure: cytology specimen collection procedure;   Procedure: diagnostic procedure;   Procedure: gene expression analysis;   Procedure: immunohistochemistry staining method;   Procedure: laboratory biomarker analysis;   Procedure: medical chart review;   Procedure: mutation analysis;   Procedure: polymerase chain reaction;   Procedure: quality-of-life assessment;   Procedure: questionnaire administration;   Procedure: study of socioeconomic and demographic variables
11 Unknown  Grouptraining for Overactive Bladder in Adults
Condition: Overactive Bladder
Interventions: Behavioral: bladdertraining in groups;   Behavioral: bladdertraining individually
12 Recruiting Combined Behavioral and Drug Treatment of Overactive Bladder in Men
Conditions: Overactive Bladder;   Lower Urinary Tract Symptoms
Interventions: Behavioral: Behavioral training;   Drug: Tolterodine + tamsulosin
13 Recruiting 3-Dimensional Conformal Radiation Therapy in Treating Patients With Bladder Cancer Who Have Undergone Transurethral Resection of the Bladder
Condition: Bladder Cancer
Interventions: Procedure: diagnostic cystoscopy;   Procedure: diffusion-weighted magnetic resonance imaging;   Procedure: implanted fiducial-based imaging;   Procedure: quality-of-life assessment;   Radiation: 3-dimensional conformal radiation therapy;   Radiation: image-guided radiation therapy;   Radiation: selective external radiation therapy
14 Not yet recruiting MK-3475/BCG in High Risk Superficial Bladder Cancer
Condition: Bladder Cancer
Intervention: Drug: Intravenous MK-3475/ Intravesical BCG
15 Recruiting Acupuncture for Female IC/PBSyndrome and Its Effect on the Urinary Microbiome: A Randomized Controlled Trial
Conditions: Painful Bladder Syndrome;   Interstitial Cystitis
Interventions: Device: standardized acupuncture treatment;   Device: Control Sham/Minimal Acupuncture
16 Unknown  Premarin Versus Toviaz for Treatment of Overactive Bladder
Condition: Overactive Bladder
Intervention: Drug: Toviaz, Premarin Vaginal Cream
17 Unknown  Endoscopic Resection of Bladder Tumors
Condition: Bladder Tumor
Intervention: Other: Endoscopic resection under blue light (Hexvix®)
18 Unknown  PF-03446962 in Relapsed or Refractory Urothelial Cancer
Condition: Transitional Cell Carcinoma of Bladder
Intervention: Drug: PF03446962
19 Recruiting Secondary Bilateral Sacral Nerve Stimulation in Overactive Bladder Patients
Condition: Bladder Hyperactivity
Intervention: Device: Device:   INTERSTIM II
20 Unknown  Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer
Conditions: Bladder Cancer;   Transitional Cell Cancer of the Renal Pelvis and Ureter;   Ureter Cancer;   Urethral Cancer
Interventions: Drug: carboplatin;   Drug: gemcitabine hydrochloride;   Drug: vandetanib;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years